Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11Osteoporosis 5Prostatic Neoplasms 4Neoplasms 4Multiple Myeloma 2Unspecified Childhood Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Smoldering Multiple Myeloma 1Regional Osteoporosis as a Result of Chemotherapy 1Recurrence 1Polycystic Ovary Syndrome 1Paraganglioma, Extra-Adrenal 1Pain 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Metabolic Syndrome 1Menstruation Disturbances 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lymphedema 1Leukemia 1Hodgkin Disease 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Depression 1Cicatrix 1Cardiovascular Diseases 1Carcinoma, Transitional Cell 1

Interventions

Metformin 2drospirenone and ethinyl estradiol combination 1cinnulin PF 1Sugars 1Population Groups 1Inositol 1Glucose Tolerance Test 1Folic Acid 1Doxycycline 1Diet 1Control Groups 1Contraceptives, Oral 1Caloric Restriction 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Menstruation Disturbances × Absorptiometry, Photon × Clear all
NCT00283816 2015-05-15

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

University of Rochester

Phase 3 Completed
36 enrolled 9 charts

Menstruation Disturbances, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡